Filing Details
- Accession Number:
- 0001127602-11-010253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-15 13:00:00
- Reporting Period:
- 2011-03-14
- Filing Date:
- 2011-03-15
- Accepted Time:
- 2011-03-15 16:50:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
946840 | Viropharma Inc | VPHM | Pharmaceutical Preparations (2834) | 232789550 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1383292 | Jr A Charles Rowland | 730 Stockton Drive Exton PA 19341 | Vp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-03-14 | 10,000 | $5.91 | 38,496 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-03-14 | 25,000 | $8.86 | 63,496 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-03-14 | 10,000 | $18.55 | 53,496 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-03-14 | 25,000 | $18.58 | 28,496 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-03-14 | 10,000 | $0.00 | 10,000 | $5.91 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-03-14 | 25,000 | $0.00 | 25,000 | $8.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2010-06-11 | 2019-06-11 | No | 4 | M | Direct |
75,000 | 2011-01-07 | 2020-01-07 | No | 4 | M | Direct |
Footnotes
- The options vest in four equal annual installments beginning on the first anniversary date from time of grant.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.535 to $18.855, inclusive.